Advertising
Showing 1 to 15 of 91 entries
PAST TOP PICK
(A Top Pick Aug 27/20, Up 40%) Trades at just over 14x earnings. Managed Covid expenses quite well. Excellent value here.
medical services
PAST TOP PICK
(A Top Pick Mar 20/20, Up 52%) Has owned it for a very long term. Second biggest health insurer. Provides health care insurers to individuals, corporations and governments. Gets best value for the money. Over time, has grown a lot. Biggest owners of Blue Cross and Blue Shield. Pays a nice growing dividend. Still undervalued here.
medical services
TOP PICK
Recent acquisition in Puerto Rico. Building out pharmacy benefit manager. Short-term volatility around commercial Medicaid. Very inexpensive. Decent growth. Less than 1 PEG ratio and visibility into that growth. Yield is 1.51%. (Analysts’ price target is $362.52)
medical services
TOP PICK
A large US health insurer (40 million Americans) and highly profitable. They'll make $26/share next year. Cheap at 12x earnings, and at least a 7% free cash flow. No, health insurance won't be in trouble when the Democrats take office, because about 170 million American hold private health insurance plans based on a 75% satisfaction rate. So, it's unlikely there'll be a radical change in American healthcare. (Analysts’ price target is $365.86)
medical services
PAST TOP PICK
(A Top Pick Aug 22/19, Up 5%) Has alliances with various companies and government. Successful. Commercial enrollments are down, as people are losing their jobs. However, medical loss ratios are positive because elective surgeries have been put off. Anticipates $26 EPS next year. Good cash flow.
medical services
TOP PICK
Insures over 40M Americans. Unlikely that Democrats would implement universal healthcare, and companies like Anthem will be part of the solution. Trading at just over 10x, very strong cash flow. Yield is 1.40%. (Analysts’ price target is $335.92)
medical services
TOP PICK
Free cashflow machine. Decreased number of outstanding shares by 60%. Increases dividend each year. Trades at 9.9x earnings, a cheap valuation. Yield is 1.48%. (Analysts’ price target is $343.09)
medical services
BUY

SYK vs. Anthem He likes both. Stryker trades at 23x PE. He owns Anthem, which hit on earnings, but the market was skittish on their expense line. It's a great healthcare company

medical services
BUY
She likes and holds it. He likes United health also. This whole managed care in the US when we go through an election cycle gets beaten down.
medical services
COMMENT

His choice in this space is Anthem, as it has better valuation metrics (13 times PE versus 17 with UnitedHealth).

medical services
PAST TOP PICK
(A Top Pick Aug 26/19, Up 11%) Second largest provider of healthcare and managed care in the US. Owns Blue Cross and Blue Shield. Great market position and branding. Help control costs in the system. Great cashflow generator. Trades at 12x PE. Yield is 1.1%.
medical services
TOP PICK
They provide health insurance to Americans; ANTM does Medicaid administration to be exact. They are big-scale nationally and concentrated in certain areas which gives them negotiating power with hospitals and doctor groups. They can cross-sell to customers eye and dental care. Also, aging demographics are a tailwind. A poorly negotiated pharmacy benefit management contract is now moving off, so that will result in an earnings pick-up. They will result in lower prices for their members that could drive revenues up. (Analysts’ price target is $330.57)
medical services
TOP PICK
A free cash flow machine. He's owned this for many years. It's retired 59% of its shares in the past 13 years. Trades at a PE of 11x. A cheap stock. Its 2% dividend will probably rise 10% next year. His 2020 EPS estimate is $22.89/share with a PE of 11x. (Analysts’ price target is $339.86)
medical services
TOP PICK
A health insurance company. Tey insure 40 out of 170 million Americans. 70 percent of people polled with private health insurance say they like it. It's going to be tough for politicians. Americans don’t like higher taxes to fund public healthcare. ANTM-N is not going away. 14 times earnings. A very well managed company. (Analysts’ price target is $399.86)
medical services
PAST TOP PICK
(A Top Pick Jul 05/18, Up 28%) Anthem is in managed care in health care, dominant in Blue Cross/Blue Shield in 13 U.S. states. It's recovered well since April when the Medicare for all calls were coming from Washington. Still likes Anthem and it continues to do well. It consistently delivers.
medical services
Showing 1 to 15 of 91 entries

Anthem Inc(ANTM-N) Rating

Ranking : 4 out of 5

Bullish - Buy Signals / Votes : 2

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 2

Stockchase rating for Anthem Inc is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Anthem Inc(ANTM-N) Frequently Asked Questions

What is Anthem Inc stock symbol?

Anthem Inc is a American stock, trading under the symbol ANTM-N on the New York Stock Exchange (ANTM). It is usually referred to as NYSE:ANTM or ANTM-N

Is Anthem Inc a buy or a sell?

In the last year, 2 stock analysts published opinions about ANTM-N. 2 analysts recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Anthem Inc.

Is Anthem Inc a good investment or a top pick?

Anthem Inc was recommended as a Top Pick by on . Read the latest stock experts ratings for Anthem Inc.

Why is Anthem Inc stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Anthem Inc worth watching?

2 stock analysts on Stockchase covered Anthem Inc In the last year. It is a trending stock that is worth watching.

What is Anthem Inc stock price?

On 2021-09-22, Anthem Inc (ANTM-N) stock closed at a price of $375.49.